The challenges of checkpoint inhibition in the treatment of multiple myeloma.

The challenges of checkpoint inhibition in the treatment of multiple myeloma.
复制标题

DOI:
10.1016/j.cellimm.2018.10.003
复制
发表时间:
2018-12
影响因子:
4.3
通讯作者:
Kang Y
Kang Y
中科院分区:
医学4区
文献类型:
--
作者:
Paul B;Kang S;Zheng Z;Kang Y

文献摘要

参考文献

被引文献

相似文献

Despite significant improvements in the overall survival of patients with multiple myeloma (MM) over the past 15 years, the disease remains incurable. Treatment options are limited for patients who have relapsed or are refractory to immunomodulatory drugs (IMiDs), proteasome inhibitors, and monoclonal antibodies. In these patients, immunotherapies such as checkpoint inhibitors, oncolytic vaccines, and chimeric antigen receptor (CAR) T cells provide a potentially effective alternative treatment. While checkpoint inhibitors are effective in prolonging overall survival in some patients with advanced solid cancers and Hodgkin lymphoma, they have not demonstrated significant anti-myeloma activities as a single agent in MM. In fact the combination of checkpoint inhibitors with IMiDs was recently found to increase the risk of death in myeloma patients. These challenges highlight the need for a better understanding of immune dysregulation in myeloma patients, and the mechanisms of action of- and resistance to- checkpoint inhibitors. In this review, we summarize immune dysfunction in patients with MM, and review the preclinical and clinical data regarding checkpoint inhibitors in myeloma. We conclude by proposing strategies to improve the efficacy and safety of checkpoint inhibitors in this population.
T细胞共刺激和共抑制的分子机制。
DOI: 10.1038/nri3405
发表时间: 2013-04
期刊: Nature reviews. Immunology
影响因子: --
作者:
通讯作者: --
DOI: 10.1182/blood-2017-03-775122
发表时间: 2017-09-07
期刊: BLOOD
影响因子: 20.3
作者:
Badros, Ashraf;Hyjek, Elizabeth;Singh, Zeba
通讯作者: Singh, Zeba
DOI: 10.1177/1758835918768238
发表时间: 2018
影响因子: 4.9
作者:
Boutsikou E;Domvri K;Hardavella G;Tsiouda D;Zarogoulidis K;Kontakiotis T
通讯作者: Kontakiotis T
破骨细胞促进多发性骨髓瘤中的免疫抑制微环境:治疗意义。
DOI: 10.1182/blood-2016-03-707547
发表时间: 2016-09-22
期刊: BLOOD
影响因子: 20.3
作者:
An, Gang;Acharya, Chirag;Anderson, Kenneth C.
通讯作者: Anderson, Kenneth C.
DOI: 10.1158/1078-0432.ccr-07-4079
发表时间: 2008-05-15
影响因子: 11.5
作者:
Berger, Raanan;Rotem-Yehudar, Rinat;Nagler, Arnon
通讯作者: Nagler, Arnon